HIGHLIGHTS
- who: Phuoc-Vinh Nguyen et al. from the , Nanomedicines and Nanoprobes, University of Tours, Tours, France have published the paper: Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines, in the Journal: Pharmaceutics 2022, 2679 of 20/Oct/2022
- what: Following the previous study on the development of EGFR-targeted nanomedicine (NMscFv) for the active delivery of siRNA in EGFR-positive cancers this study focuses on the development and the quality control of a radiolabeling method to track it in in vivo conditions with nuclear imaging. Before evaluating its in_vivo anticancer activity and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.